Although NIDA puts the contract up for bid every 5 years, it has awarded this contract solely to NCNPR since 1968.
NCNPR has thus been the only federally-permitted source of cannabis, which it can distribute to researchers only as directed by NIDA—a situation that both entities hesitate to call a monopoly.
Lyle E. Craker, PhD, a professor of plant and soil sciences at the University of Massachusetts, applied directly to DEA in 2001 to be a private cultivator of cannabis for medicinal research.
DEA then proposed to reject Dr. Craker’s application, saying that the Single Convention requires the federal government to limit cannabis available for research to one source.
Please allow doctors, scientists, and other publicly considered reputable institutions to study the effects of Cannabis.